TY - JOUR
T1 - Meeting Highlights The 4th Marie Skłodowska-Curie Symposium on cancer research and care
T2 - Mechanisms of support for regional & international collaborations
AU - Kalinski, Pawel
AU - Kokolus, Kathleen M.
AU - Ahluwalia, Indu
AU - Balu, Mihaela
AU - Balwicki, Łukasz
AU - Baran, Brygida
AU - Beine, Loretta
AU - Berezin, Mikhail
AU - Berindan-Neagoe, Ioana
AU - Beznosenko, Andriy
AU - Borowiec, Blanka
AU - Bozsányi, Szabolcs
AU - Bramson, Jonathan
AU - Czerniecki, Brian
AU - Everatt, Rūta
AU - Fendler, Wojciech
AU - Forsyth, Peter
AU - Gershenwald, Jeffrey E.
AU - Goniewicz, Maciej
AU - Guru, Khurshid
AU - Hyland, Andrew
AU - James, Smitha
AU - Kirac, Iva
AU - Koczkodaj, Pawel
AU - Kotula, Leszek
AU - Łuba, Maciej
AU - Ługowska, Iwona
AU - Luke, Elizabeth
AU - Lungulescu, Cristian
AU - Matosevic, Sandro
AU - Nanavati, Kaushal
AU - Nemeth, Michael
AU - Nowak, Karolina
AU - Noyes, Katia
AU - Parascandola, Mark
AU - Priebe, Waldemar
AU - Rutkowski, Piotr
AU - Seshadri, Mukund
AU - Sheffer, Christine E.
AU - Stanciu, Ioana Miruna
AU - Stanson, Joanna
AU - Stewart, Telisa
AU - Sužiedėlienė, Edita
AU - Sužiedėlis, Kęstutis
AU - Tanasiichuk, Iryna
AU - Vlad, Anda M.
AU - Wei, Wei Zen
AU - Williams, Dylan
AU - Wojtowicz, Malgorzata
AU - Zdrojewski, Tomasz
PY - 2025
Y1 - 2025
N2 - The Marie Skłodowska-Curie Symposia on Cancer Research and Care (MSCS-CRC) promote collaborations between cancer researchers and care providers in the United States, Canada and Central and Eastern European Countries (CEEC) to accelerate the development of new cancer therapies, new strategies for early detection and prevention, and improve cancer care and the quality of life for patients and their families. The 4th MSCS-CRC (September 25-27, 2024, Buffalo, New York) brought together 147 participants from the US, Canada, Croatia, Czechia, Lithuania, Poland, Romania and Ukraine, and involved representatives of the US Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI) and their counterparts from Poland, Ukraine Lithuania and other CEECs. They were accompanied by New York State (NYS) and local representatives of the NYS Empire State Development, and of the Translational Research Consortium of Cancer Centers (TRCCC), involving 13 cancer centers from the Northeastern US and Canada, as well as several Pharma and Biotech companies. The 4th Meeting focused on prevention and early detection of smoking- and HPV-related cancers, reducing disparities in cancer detection-, care and outcomes, and increasing the feasibility and reducing costs of high-end treatments, such as cell therapies for patients with advanced cancers. The second focus area were the available sources of funding of regional and international collaborations in these areas. The relevance of the successful model TRCC to promoting the oncology training and research collaborations in the CEE Countries was discussed. The 5th MSCR-CRC meeting will take place September 3-5, 2025, in Warsaw, Poland.
AB - The Marie Skłodowska-Curie Symposia on Cancer Research and Care (MSCS-CRC) promote collaborations between cancer researchers and care providers in the United States, Canada and Central and Eastern European Countries (CEEC) to accelerate the development of new cancer therapies, new strategies for early detection and prevention, and improve cancer care and the quality of life for patients and their families. The 4th MSCS-CRC (September 25-27, 2024, Buffalo, New York) brought together 147 participants from the US, Canada, Croatia, Czechia, Lithuania, Poland, Romania and Ukraine, and involved representatives of the US Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI) and their counterparts from Poland, Ukraine Lithuania and other CEECs. They were accompanied by New York State (NYS) and local representatives of the NYS Empire State Development, and of the Translational Research Consortium of Cancer Centers (TRCCC), involving 13 cancer centers from the Northeastern US and Canada, as well as several Pharma and Biotech companies. The 4th Meeting focused on prevention and early detection of smoking- and HPV-related cancers, reducing disparities in cancer detection-, care and outcomes, and increasing the feasibility and reducing costs of high-end treatments, such as cell therapies for patients with advanced cancers. The second focus area were the available sources of funding of regional and international collaborations in these areas. The relevance of the successful model TRCC to promoting the oncology training and research collaborations in the CEE Countries was discussed. The 5th MSCR-CRC meeting will take place September 3-5, 2025, in Warsaw, Poland.
KW - Symposium
KW - cancer care
KW - cancer research
KW - international collaborations
KW - regional collaborations
UR - https://www.scopus.com/pages/publications/105002001910
U2 - 10.36740/WLek/202370
DO - 10.36740/WLek/202370
M3 - Article
C2 - 40125737
AN - SCOPUS:105002001910
SN - 0043-5147
VL - 78
SP - 232
EP - 247
JO - Wiadomosci Lekarskie
JF - Wiadomosci Lekarskie
IS - 2
ER -